Skip to main content
The Egyptian Journal of Neurology, Psychiatry and Neurosurgery

Table 1 A comparison of serum biomarkers levels in both patient groups

From: Cardio embolic stroke and blood biomarkers: diagnosis and predictors of short-term outcome

Blood biomarkers

Group Ι (CES)

Group ΙΙ (non-CES)

Test of significance(t test)

P

BNP

 Mean ± SD (pg/ml) range

134.6 ± 93.3 (100–420)

68.33 ± 12.69 (50–95)

− 5.046

< 0.001**

CK-MB

 Mean ± SD (ng/ml) range

1.61 ± 0.59 (0.5–2.6)

0.76 ± 0.19 (0.5–1)

9.49

< 0.001**

d-Dimer

 Mean ± SD (ng/ml) range

613.19 ± 275.02 (250–1090)

277.92 ± 80.16 (100–500)

8.109

< 0.001**

CRP

 Mean ± SD (mg/l) range

28.72 ± 26.31 (5–100)

34.91 ± 27.39 (5–109)

−1.129

0.262

G/A ratio

 Mean ± SD range

0.73 ± 0.04 (0.63–0.79)

0.71 ± 0.06 (0.62–0.79)

1.369

0.175

  1. CES cardio-embolic stroke, non CES non-cardio-embolic stroke, BNP brain natriuretic peptide, CK-MB creatine–kinase, CRP C-reactive protein, G/A globulin/albumin
  2. **Statistically highly significant
Back to article page